We serve D-Glutamine CAS:5959-95-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Solubility in 3M-HCl | Colorless & clear (c=5) |
| Specific rotation (20℃) | -32.4°～-36.2°(c= 1, 6M-HCl) |
| Loss on drying | Not more than 0.3% |
| Residue on ignition (as sulfate) | Not more than 0.1% |
| Chloride (Cl) | Not more than 0.03% |
| Sulfate (SO4) | Not more than 0.03% |
| Heavy metals (as Pb) | Not more than 10ppm |
| Iron (Fe) | Not more than 10ppm |
| Arsenic (As2O3) | Not more than 1ppm |
| Other amino acid (D-Glu) | Not more than 1.0% by T.L.C.(The spotted amount, 50μg) |
| Assay | 98.5%～101.0% |
| L-Isomer | Not more than 0.5% |
Contact us for information like D-Glutamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,H-D-Gln-OH physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,D-2-Aminoglutaramic acid Use and application,D-2-Aminoglutaramic acid technical grade,usp/ep/jp grade.
Related News: Chinese nationals coming from China and connecting through another foreign airport will be denied travel. Those with pre-clearance are exempted.4-Iodobiphenyl manufacturer In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.5-Bromo-2-Hydroxy-3-Picoline supplier In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.L-Homoserine vendor Here’s what we can tell you so far:In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .
